The store will not work correctly when cookies are disabled.
(1-((1,3-Diphenyl-1H-pyrazol-4-yl)methyl)-1H-1,2,3-triazol-4-yl)methanol
ID: ALA4216760
PubChem CID: 145971654
Max Phase: Preclinical
Molecular Formula: C19H17N5O
Molecular Weight: 331.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: OCc1cn(Cc2cn(-c3ccccc3)nc2-c2ccccc2)nn1
Standard InChI: InChI=1S/C19H17N5O/c25-14-17-13-23(22-20-17)11-16-12-24(18-9-5-2-6-10-18)21-19(16)15-7-3-1-4-8-15/h1-10,12-13,25H,11,14H2
Standard InChI Key: YAAOFRQETIMQJJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
3.0995 -13.4548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9208 -13.4548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1793 -12.6740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5122 -12.1877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8494 -12.6740 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5110 -11.3665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2239 -10.9575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2230 -10.1369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5100 -9.7244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7964 -10.1426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8008 -10.9618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3212 -14.1605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1384 -14.1667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6827 -14.1605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8621 -14.1496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4453 -14.8545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8482 -15.5693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6720 -15.5749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0850 -14.8694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6155 -14.8301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3946 -14.5834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4008 -13.7662 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6255 -13.5080 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0521 -15.0688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8011 -14.7420 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
4 6 1 0
2 12 1 0
12 13 1 0
1 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
13 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 13 1 0
21 24 1 0
24 25 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 331.38 | Molecular Weight (Monoisotopic): 331.1433 | AlogP: 2.67 | #Rotatable Bonds: 5 |
Polar Surface Area: 68.76 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.87 | CX Basic pKa: 1.37 | CX LogP: 3.18 | CX LogD: 3.18 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.61 | Np Likeness Score: -1.90 |
References
1. Dayakar C, Kumar BS, Sneha G, Sagarika G, Meghana K, Ramakrishna S, Prakasham RS, China Raju B.. (2017) Synthesis, pharmacological activities and molecular docking studies of pyrazolyltriazoles as anti-bacterial and anti-inflammatory agents., 25 (20): [PMID:28927905] [10.1016/j.bmc.2017.08.042] |